Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 11 announcements

Share price
₹1,360.90
Market cap
₹1,944 Cr
Revenue (annual)
₹635.5 Cr
Net profit (annual)
₹32.62 Cr
P/E (TTM)
44.4×Sector 50.4×
Promoter holding
44.57%+0.40% QoQ
FII holding
1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:38 IST BSE
Financial Results

Fredun Pharmaceuticals Q1 FY27 Results: Net Profit ₹13.1 Cr, Up 92.6% YoY

Fredun Pharmaceuticals Ltd reported revenue from operations of ₹227.8 Cr (+90.8% YoY) and net profit of ₹13.1 Cr (+92.6% YoY) for Q1 FY27.

Key figure
Net profit ₹13.1 Cr · +92.6% YoY